OncoSeq®

The OncoSeq® Cancer Screening range of tests, employs Next Generation Sequencing technology to identify genetic variants associated with hereditary cancer risk.

OncoSeq® offers a choice of tests to allow patients and healthcare providers to choose from the most common genes involved in cancer link like BRCA1 and BRCA2, to the most comprehensive hereditary cancer screening panel with 50 genes that have been reported to be associated with increased risk of developing cancer.

OncoSeq® helps identifying higher risk individuals, as well as understand the genetic roots of cancer for patients, making it possible to take preventative actions to avoid recurrence and prevent occurrence of cancer, unlike screening methodologies like Mammography, PSA testing and others, OncoSeq® truly contributes to the prevention of cancer, rather than early detection.
The OncoSeq® range covers almost all cancers that may have a genetic risk factor, this includes Breast, ovarian, Prostate, Colon and many others.

The OncoSeq® range of cancer screening tests comes with optional clinical genetic counseling to help individuals understand if this test is right for them and help tested subjects understand their test results and how to deal with them.

OncoSeq® is the right step on the path of cancer prevention.

Request a Test

OncoSeq® Reports

OncoSeq® offers comprehensive clinical reports with clinically relevant findings for a variety of hereditary cancers

Report Gene Cancer(s)
OncoSeq C Read of 9 Genes - BRCA1, BRCA2, APC, MLH1, MSH2, MSH6, MUTYH, PMS2, TP53
  • Breast-ovarian cancer
  • Medulloblastoma
  • Breast adenocarcinoma
  • Prostate cancer
  • Brain tumor-polyposis syndrome
  • Adenomatous polyposis coli
  • Gardner syndrome
  • Lynch syndrome
  • Colorectal cancer
  • Li-Fraumeni syndrome
  • Fanconi anemia
  • Mismatch repair cancer syndrome
  • Adenomas, multiple colorectal
    •  .... Read More
OncoSeq S Read of 20 Genes - PALB2, PTEN, BRIP1, PTCH1, RAD50, RAD51C, APC, MUTYH, PIK3CA, ATM, BRCA1, BRCA2, CHEK2, RAD51D, EPCAM, MLH1, MSH2, MSH6, PMS2, TP53
  • Breast-ovarian cancer
  • Cowden syndrome
  • Basal cell nevus syndrome
  • Gastric adenocarcinoma and proximal polyposis of the stomach
  • Prostate cancer
  • Tumor predisposition syndrome - breast/prostate/colorectal
  • Lynch syndrome
  • Muir-Torre syndrome
  • Endometrial cancer, familial
  • Mismatch repair cancer syndrome
  • Colorectal cancer
  • Li-Fraumeni syndrome
  • Fanconi anemia
  • Adenomas, multiple colorectal
  • Medulloblastoma
    • .... Read More
OncoSeq X Read of 50 Genes - ATM, APC, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, FAM175A, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, PALB2, PIK3CA, PMS2, PMS2CL, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53, XRCC2, NF1, SPRED1, MEN1, RET, SMARCB1, NF2, LZTR1C, TNNB1, KRAS, ERBB2, ALK, EGFR, RB1, CDKN2A, CDK4, FLCN, RUNX1, XPC, WRN, PTCH1, CDKN1C, SMAD4, HRAS
  • Gardner syndrome
  • Gastric adenocarcinoma and proximal polyposis of the stomach
  • Breast-ovarian cancer
  • Medulloblastoma
  • Prostate cancer
  • Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate
  • Tumor predisposition syndrome - breast/prostate/colorectal
  • Muir-Torre syndrome
  • Lynch syndrome
  • Endometrial cancer
  • Leukemia, acute lymphoblastic
  • Cowden syndrome
  • Peutz-Jeghers syndrome
  • Basal cell carcinoma
  • Colorectal cancer
  • Bone marrow failure syndrome
  • Li-Fraumeni syndrome
  • Leukemia, juvenile myelomonocytic
  • Multiple endocrine neoplasia
  • Medullary thyroid carcinoma
  • Multiple endocrine neoplasia IIA
  • Rhabdoid tumor predisposition syndrome
  • Lung adenocarcinoma, colon adenocarcinoma, prostate adenocarcinoma, hepatocellular carcinoma
  • Nonsmall cell lung cancer
  • Retinoblastoma
  • Melanoma-pancreatic cancer syndrome
  • Melanoma, cutaneous malignant
  • Leukemia, acute myeloid
  • Platelet disorder, familial, with associated myeloid malignancy
  • Fanconi anemia
  • Glioblastoma
  • Mismatch repair cancer syndrome
  • Adenomas, multiple colorectal
    • .... Read More

Who should get OncoSeq® Screening done?

  • An individual who is diagnosed with the cancer
  • When there is a family history of cancer
  • When there is an increased risk of cancer
  • When you are worried about the risk of cancer

Sample Requirement

  • DNA in TE Buffer or Water or Peripheral Blood in EDTA Tubes

For more details about each panel and a complete list of syndromes, please contact our partners